Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039103 | SCV000062785 | benign | not specified | 2012-04-17 | criteria provided, single submitter | clinical testing | Leu527Leu in exon 14A of CDH23: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, it is not located wi th the splice consensus sequence, and has been identified in 1376/8220 (16.8%) E uropean American chromosomes and 423/3790 (11.2%) African American chromosomes b y the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu; dbSNP rs2305 209). |
Gene |
RCV000039103 | SCV000731164 | benign | not specified | 2017-06-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genome- |
RCV001533644 | SCV001750371 | benign | Usher syndrome type 1D | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001533645 | SCV001750372 | benign | Autosomal recessive nonsyndromic hearing loss 12 | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490533 | SCV002796196 | benign | Autosomal recessive nonsyndromic hearing loss 12; Usher syndrome type 1D; Pituitary adenoma 5, multiple types | 2021-12-22 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004717934 | SCV005321730 | benign | not provided | criteria provided, single submitter | not provided |